Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial.
Huddart R, Hafeez S, Omar A, Alonzi R, Birtle A, Cheung KC, Choudhury A, Foroudi F, Gribble H, Henry A, Hilman S, Hindson B, Lewis R, Muthukumar D, McLaren DB, McNair H, Nikapota A, Olorunfemi A, Parikh O, Philipps L, Rimmer Y, Syndikus I, Tolentino A, Varughese M, Vassallo-Bonner C, Webster A, Griffin C, Hall E. Huddart R, et al. Among authors: webster a. Clin Oncol (R Coll Radiol). 2023 Sep;35(9):586-597. doi: 10.1016/j.clon.2023.05.002. Epub 2023 May 9. Clin Oncol (R Coll Radiol). 2023. PMID: 37225552 Clinical Trial.
Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials.
Yang H, Mir R, Díez P, Tsang Y, Conibear J, Simões R, Cox S, Webster A, Nabi Z, Eaton D, Naismith O, Whilde N, Miles E. Yang H, et al. Among authors: webster a. Clin Oncol (R Coll Radiol). 2020 Feb;32(2):e60-e66. doi: 10.1016/j.clon.2019.09.054. Epub 2019 Oct 11. Clin Oncol (R Coll Radiol). 2020. PMID: 31607614
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.
Hafeez S, Webster A, Hansen VN, McNair HA, Warren-Oseni K, Patel E, Choudhury A, Creswell J, Foroudi F, Henry A, Kron T, McLaren DB, Mitra AV, Mostafid H, Saunders D, Miles E, Griffin C, Lewis R, Hall E, Huddart R. Hafeez S, et al. Among authors: webster a. BMJ Open. 2020 Dec 31;10(12):e041005. doi: 10.1136/bmjopen-2020-041005. BMJ Open. 2020. PMID: 33384390 Free PMC article.
Recognising the challenges of implementing multi-centre adaptive plan of the day radiotherapy.
Webster A, McNair HA, Hansen VN, Lewis R, Patel E, Miles E, Hall E, Hafeez S, Huddart R; RAIDER, HYBRID Trial Management Groups. Webster A, et al. Tech Innov Patient Support Radiat Oncol. 2022 Feb 9;21:31-35. doi: 10.1016/j.tipsro.2022.01.002. eCollection 2022 Mar. Tech Innov Patient Support Radiat Oncol. 2022. PMID: 35198744 Free PMC article.
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial.
Hudson EM, Noutch S, Brown S, Adapala R, Bach SP, Burnett C, Burrage A, Gilbert A, Hawkins M, Howard D, Jefford M, Kochhar R, Saunders M, Seligmann J, Smith A, Teo M, Webb EJ, Webster A, West N, Sebag-Montefiore D, Gollins S, Appelt AL. Hudson EM, et al. Among authors: webster a. BMJ Open. 2022 Apr 28;12(4):e049119. doi: 10.1136/bmjopen-2021-049119. BMJ Open. 2022. PMID: 35487526 Free PMC article.
1,701 results